70 PROJECTS COMPETE FOR AN ESTEVE GRANT FOR HEALTH-RELATED INNOVATION IN "CHRONIC PATIENT CARE"
The purpose of this initiative is to improve the chronic patient's quality of life and to foster innovation among healthcare providers in the field of chronicity.
Three 10,000-euro grants will be awarded.
The categories are: High Complexity Chronic Patients, Medium Complexity Chronic Patients, and Low Complexity Chronic Patients.
ESTEVE has received 70 projects competing for one of the three 2013 Grants for Health-Related Innovation in "Chronic Patient Care". The second edition of this initiative supports the performance of a really innovative project addressing chronic non-communicable diseases to improve the quality of life and healthcare of these patients. Winners will be revealed on April 13th at the V National Congress of Chronic Patient Care held in Barcelona.
The increasing number of chronic patients ―a consequence of ageing populations― poses a major challenge to the sustainability of the healthcare system on account of the high costs involved. That is why ESTEVE ―with wide experience in the most relevant areas of chronicity, such as cardiovascular, renal, respiratory, osteoarticular and nervous system― announces the Grants for Health-Related Innovation in "Chronic Patient Care".
These grants are intended to help improve the chronic patient's quality of life, to promote healthy life habits, and to prevent chronic communicable diseases. Yet, another goal is to foster innovation ―an indispensable tool to face the challenges of chronicity― among healthcare providers, as well as to encourage participation among the system's different actors and levels, and to promote research, training and chronicity knowledge management.
Three grants are awarded, one for each of the following areas: High Complexity Chronic Patients, Medium Complexity Chronic Patients, and Low Complexity Chronic Patients, each endowed with a maximum of 10,000 euros.
Almost half of the 70 projects received (48%) are included in the High Complexity Chronic Patient category, totaling 34 proposals. The Medium Complexity Chronic Patient and the Low Complexity Chronic Patient follow with 26% each, totaling 18 proposals in both cases.
Also importantly, the projects competing for one of the three ESTEVE Grants for Health-Related Innovation this year correspond to 23 different specialties, led by Primary Care and Nursing (19 proposals) and followed by Internal Medicine (6), Hospital Pharmacy (5) and Endocrinology, Psychology and Research (4 each). The rest is distributed among Geriatrics, Orthopedic Surgery, Cardiology, Vascular Surgery, Physiotherapy, Pneumology, Neurology, Oncology or Psychiatry, among others.
Also, this year's edition includes healthcare providers, both on an individual and group basis, from 11 Autonomous Communities. The projects submitted are led in number by Catalonia, Madrid and Andalusia, followed by the Valencian Community, Galicia, Aragon, the Basque Country, Castilla León, Castilla-La Mancha, and Cantabria.
Three categories according to the level of chronicity
Each of the three ESTEVE Grants for Health-Related Innovation in "Chronic Patient Care" addresses one of three categories according to the different needs of the population with chronic non-communicable diseases.
Low Complexity Chronic Patients: Individuals with little development of their risk factors or chronic conditions. Proposals include projects to help patients take the lead in managing their disease, and also projects that foster the core of healthcare (family doctors, nursing staff, and specialists).
Medium Complexity Chronic Patients: Individuals with advanced chronic diseases and at risk of complications, but still able to perform self-care routines.
High Complexity Chronic Patients: Individuals with multiple chronic diseases or with a severe chronic disease, frequently involving disability, flare-ups and loss of functional ability.
The jury will be formed by the members of the Scientific Committee of the V Congress of Chronic Patient Care, and will select the winners of the 2013 ESTEVE Grants based on the following criteria: innovation, scientific and technical quality, viability and applicability in other areas or territories, and teamwork and multidisciplinary collaboration involved in the projects.
The winners will be revealed at the V National Congress of Chronic Patient Care, to be held at the International Convention Center of Barcelona (CCIB) on April 11th, 12th and 13th.
Follow ESTEVE at Twitter's link twitter.com/esteve_news.
THE PROGRAM ’PLAN PROFARMA’ HAS ONCE AGAIN QUALIFIED ESTEVE’S R&D&I AS ’’EXCELLENT’’
Once again, ESTEVE's research activity has received the qualification ''Excellent'' in the Program 'Plan Profarma' (Program for Fostering Scientific Research, Technological Development and Innovation ...read more
PENSA PHARMA HAS BEEN AWARDED A PRIZE FOR ITS BEST DEVELOPMENT AND COMMERCIALIZATION OF GENERIC MEDICINES
Pensa Pharma (PENSA), a company of the ESTEVE Group specialized in generic medicines, has been awarded a prize at the II edition of La Razón Comunidad Valenciana Awards. Specifically, PENSA has receiv...read more
ESTEVE APPOINTS THOMAS B. RIISAGER AS CHIEF CORPORATE STRATEGY & BUSINESS DEVELOPMENT OFFICER
ESTEVE has announced today the appointment of Thomas B Riisager as Chief Corporate Strategy & Business Development Officer, to be heading Corporate Strategy & Business Development for the pharmaceutic...read more